AAMU
BSX icon

Amundi Asset Management US’s Boston Scientific BSX Stock Holding History

Amundi Asset Management US’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$157M Buy
4,074,765
+359,114
+10% +$13.6M 0.12% 187
2020
Q4 		$134M Buy
3,715,651
+1,382,000
+59% +$49.8M 0.11% 199
2020
Q3 		$89.2M Buy
2,333,651
+333,218
+17% +$12.8M 0.09% 219
2020
Q2 		$70.2M Buy
2,000,433
+457,769
+30% +$16.5M 0.08% 250
2020
Q1 		$50.3M Sell
1,542,664
-460,848
-23% -$18M 0.09% 218
2019
Q4 		$90.6M Sell
2,003,512
-113,067
-5% -$4.73M 0.11% 190
2019
Q3 		$86.1M Buy
2,116,579
+147,124
+7% +$6.23M 0.13% 177
2019
Q2 		$84.6M Sell
1,969,455
-1,531,011
-44% -$58.9M 0.07% 214
2019
Q1 		$134M Sell
3,500,466
-227,114
-6% -$8.67M 0.19% 118
2018
Q4 		$132K Buy
3,727,580
+770,542
+26% +$27.9M 0.12% 126
2018
Q3 		$114M Buy
2,957,038
+325,960
+12% +$11.4M 0.15% 150
2018
Q2 		$86M Buy
2,631,078
+1,788,351
+212% +$53.9M 0.12% 181
2018
Q1 		$23M Sell
842,727
-11,851
-1% -$322K 0.04% 442
2017
Q4 		$21.2M Sell
854,578
-1,010,415
-54% -$27.9M 0.03% 446
2017
Q3 		$54.4M Sell
1,864,993
-109,827
-6% -$3.03M 0.17% 114
2017
Q2 		$54.7M Buy
1,974,820
+36,143
+2% +$959K 0.18% 113
2017
Q1 		$48.2M Sell
1,938,677
-2,340
-0.1% -$56.9K 0.16% 118
2016
Q4 		$42M Buy
1,941,017
+62,256
+3% +$1.36M 0.15% 124
2016
Q3 		$44.7M Sell
1,878,761
-1,084,102
-37% -$25.9M 0.16% 116
2016
Q2 		$69.2M Sell
2,962,863
-824,246
-22% -$17.8M 0.25% 95
2016
Q1 		$71.2M Buy
3,787,109
+118,963
+3% +$2.09M 0.26% 89
2015
Q4 		$67.6M Buy
3,668,146
+29,109
+0.8% +$522K 0.25% 103
2015
Q3 		$59.7M Buy
3,639,037
+152,486
+4% +$2.61M 0.24% 115
2015
Q2 		$61.7M Buy
3,486,551
+737,006
+27% +$13.2M 0.23% 125
2015
Q1 		$48.8M Buy
+2,749,545
New +$43.5M 0.17% 149
2013
Q3 		– Sell
-14,623
Closed -$136K – 611
2013
Q2 		$136K Buy
+14,623
New +$124K ﹤0.01% 610

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Amundi Asset Management US's BSX Position: Q1 2021 in Review

Amundi Asset Management US increased its Boston Scientific (BSX) stake by 9.7% in Q1 2021, buying an estimated $13.6M and bringing the position to 4,074,765 shares worth $157M. The position accounts for 0.12% of the portfolio, ranked #187.

Amundi Asset Management US first reported a position in BSX in Q2 2013 and has held it in 26 quarters since. 831 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Amundi Asset Management US held 4,074,765 shares of Boston Scientific worth $157M as of Q1 2021.
  • Amundi Asset Management US bought 359,114 Boston Scientific shares in Q1 2021, an estimated $13.6M.
  • Boston Scientific made up 0.12% of Amundi Asset Management US's portfolio in Q1 2021, its #187 holding.
  • Amundi Asset Management US first reported a position in Boston Scientific in Q2 2013 and has held it in 26 quarters since.
  • 831 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.